Fiduciary

In the context of an employer-sponsored 401(k) plan, a fiduciary is a person or entity entrusted with the responsibility of managing and overseeing the plan in the best interest of the plan participants. Fiduciaries have a legal obligation to act prudently and ethically, placing the interests of the plan participants above their own. They are required to make informed and unbiased decisions, ensuring the plan's assets are invested wisely and that fees and expenses are reasonable.

 

Examples:

 

  • Investment Fiduciary: This type of fiduciary is responsible for selecting and monitoring the investment options offered within the 401(k) plan. They must carefully assess the risk and return characteristics of each investment, striving to provide a diversified lineup that suits the varying risk profiles of plan participants.

  • Named Fiduciary: In some cases, the employer itself may act as the named fiduciary, taking on the overall responsibility for the administration and operation of the 401(k) plan. This includes ensuring compliance with legal regulations and communicating plan details to participants.

  • Third-Party Fiduciary: Some employers hire external organizations or consultants to act as fiduciaries for their 401(k) plans. These third-party fiduciaries provide expertise in managing retirement plans, reducing potential conflicts of interest, and offering specialized knowledge in compliance matters.

 

In conclusion, fiduciaries play a crucial role in safeguarding the financial well-being of employees who participate in employer-sponsored 401(k) plans, making sure that the management of the plan is carried out prudently and with unwavering loyalty to the plan participants' interests.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.